Game-Changing Monthly Medicare Insights Across the Product Lifecycle

We actively immerse ourselves in the world of Medicare claims data, gaining a deep understanding of diseases, treatments, healthcare providers, and markets. This expertise enables us to enhance patient care and boost return on investment for pharmaceutical and biotech companies.
 

Game-Changing Monthly Medicare Insights Across the Product Lifecycle

We actively immerse ourselves in the world of Medicare claims data, gaining a deep understanding of diseases, treatments, healthcare providers, and markets. This expertise enables us to enhance patient care and boost return on investment for pharmaceutical and biotech companies.
 
Pre-Clinical Strategy
CareSet's census-level Medicare data and expertise streamline early drug development by identifying indications, understanding payors, and informing pre-clinical decisions for strategic pharmaceutical progress..
Clinical Trial Recruitment
CareSet streamlines clinical operations and patient enrollment for manufacturers, enhancing decentralized trials and ethnic diversity.
Market Access (Late Stage Clinical Development and Pre-launch Strategy)
In late-stage clinical development, CareSet's expertise in patient journey mapping, targeting thought leaders, and MarketView insights crucially aids pharmaceutical companies in market valuation, pricing strategies, and brand management.
Commercial Operations (Sales Excellence and Effectiveness)
CareSet equips commercial teams with essential data on market trends, healthcare provider management, and patient transitions, enhancing adoption strategies.
Regulatory
Our expertise in Medicare claims data enables pharmaceutical companies to navigate Part D regulations, manage rebates with discarded drug data analysis, and ensure compliance with regulations using LIS data.

Solutions that Deliver Impactful Product Life Cycle Insights.

CareSet’s census-level Medicare data and expertise streamline early drug development by identifying indications, understanding payors, and informing pre-clinical decisions for strategic pharmaceutical progress.
 
CareSet streamlines clinical operations and patient enrollment for manufacturers, enhancing decentralized trials and ethnic diversity.
 
In late-stage clinical development, CareSet’s expertise in patient journey mapping, targeting thought leaders, and MarketView insights crucially aids pharmaceutical companies in market valuation, pricing strategies, and brand management.
 
CareSet equips commercial teams with essential data on market trends, healthcare provider management, and patient transitions, enhancing adoption strategies.
 
Our expertise in Medicare claims data enables pharmaceutical companies to navigate Part D regulations, manage rebates with discarded drug data analysis, and ensure compliance with regulations using LIS data.
 

Smarter Insights: Navigating Pharma's Drug Lifecycle with CareSet

CareSet teams up with pharma companies, offering smart and data-driven support at every stage of a drug’s journey. We blend innovation with practicality, providing Medicare expertise and insights that make a real difference in navigating the complex drug lifecycle.
  • Treatment Journey
  • Disease Benchmark Impact
  • MarketView
  • Disease Benchmark Impact
  • KOL Targeting
  • Health EquityMarketView
  • Part D Payer and Plan-Level DataMarketView
  • HEOR/Medical Value Liaisons DatasetDisease Benchmark Impact
  • Medical Science Liaison (MSLs) Physician Profiles
  • Treatment Journey
  • Diagnostic Journey
  • Market View by Pharmacy Type
  • Monthly Alerts
  • Treatment Journey
  • Diagnostic Journey
  • MarketView
  • Targeting
  • Referrals
  • Affiliations
  • Out of Pocket Tracker
  • IRA Part D Spending Dashboard
  • Biologic Discard Rebate (HR3684)
  • LIS/Catastrophic

Pre-clinical Strategy

Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient journey to diagnosis.
MarketView: Insights for market sizing, forecasting by indication, treatment, and brand.
Disease Benchmark Impact: Assessment of disease impact, aiding in healthcare challenges.

Market Access

Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Patient  journey to diagnosis.
Market View by Pharmacy Type: Insights into pharmacy sales, payments, and PBM contracting.
Part D Payer and Plan-Level Data: Regional plan utilization insights by plan, provider, even for blocked accounts.
HEOR: Medical Value Liaisons Dataset.Medical Science Liaison (MSLs): Physician profiles.

Commercial Operations

Monthly Alerts: Physician-level alerts for field decision-making.
Treatment Journey: Patient longitudinal experience.
Diagnostic Journey: Journey to diagnosis.
MarketView: Monthly market share reports by indication, treatment, and brand.
Targeting: Activity data for prescriptions, identifying managing HCPs and their affiliated HCOs.
Referrals: Track healthcare providers referring patients to specialists.
Affiliations: Uncover financial relationships between providers.
Out-of-Pocket Tracker: Identify brand-eligible patients  while controlling out-of-pocket costs.

Clinical Trial Recruitment

KOL Targeting: Streamline clinical operations for manufacturers, enhancing decentralized trials by leveraging investigators’ networks and proximity alerts within a 4-hour drive.
Health Equity: Use race, ethnicity and income data of Medicare patients to help with clinical trial recruitment.

Clinical Trial Recruitment

IRA Part D Spending Dashboard: Up-to-date Part D gross expenditure to identify high-cost drugs.
Biologic Discard Rebate (HR3684): Cost accrual for national discarded biologic medications reported by brand for rebate management.
LIS/Catastrophic: Utilizing LIS data for targeting and supporting regulatory compliance.
Our strategic partnerships have empowered us to grant access to vital healthcare data and harness its full potential for actionable insights. We’ve mobilized this data, offering insights into physicians’ diagnostic criteria, treatment approaches, and delving into more complex questions. Our data has become invaluable to stakeholders, including pharmaceutical companies seeking NPI-level analysis and market-relevant insights.
 

Transforming Medicare Data into Solutions for Healthcare's Unmet Needs

Empowering Pharmaceutical Companies with Actionable Insights from Medicare Data

Early Success

Our inaugural release, DocGraph Hop Teaming Dataset, granted researchers, journalists, nonprofits, and data scientists unprecedented insight into healthcare provider collaborations, fostering pivotal partnerships with ProPublica, the Wall Street Journal, the Robert Wood Johnson Foundation, and even the White House.

Mission

A life-changing diagnosis catalyzed our founders’ Freedom of Information Act (FOIA) request to HHS, encompassing CMS databases. The profound clarity derived from this access has become our driving force—to unlock and utilize data to help improve health outcomes.
At CareSet, we transcend being just a data company; our mission is deeply rooted in the intersection of public policy, data journalism, and medical innovation, dedicated to unlocking and demystifying Medicare data to illuminate patient journeys in healthcare.
 

Leadership Team

CareSet is transforming the way biomedical companies go to market. We believe in getting the best treatments to the right patients quickly and efficiently. We analyze government data sources, such as Medicare claims data. With CareSet, biomedical companies have become better at serving the patient community.
 

Ashish Patel

CEO and Founder

An accomplished analyst, data scientist and journalist before co-founding CareSet, Ashish is the visionary leader and healthcare data transparency advocate.

John Beriont

Chief Commercial Officer

A successful healthcare executive, entrepreneur and pharmaceutical veteran, John brings more than 35 years of management, business operations and B2B experience.

Michael Antonoff

Chief Operating Officer

With over two decades of experience, Michael Antonoff has been a driving force in the field of data management, analytics, and artificial intelligence.